- Home
- NLOP vs AMRN Comparison
NLOP vs AMRN Comparison
Compare NLOP & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NLOP | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 339.8M |
| IPO Year | 2022 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NLOP | AMRN |
|---|---|---|
| Price | $13.95 | $15.05 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 288.9K | 85.9K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 48.56% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | $118,915,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $12.76 | $0.39 |
| 52 Week High | $34.53 | $20.90 |
Technical Indicators
Market Signals| Indicator | NLOP | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 32.67 | 49.27 |
| Support Level | $12.76 | $14.65 |
| Resistance Level | $14.70 | $16.94 |
| Average True Range (ATR) | 0.41 | 0.76 |
| MACD | 0.22 | 0.07 |
| Stochastic Oscillator | 38.80 | 42.98 |
Price Performance
Historical ComparisonAbout NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.